{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T08:01:26Z","timestamp":1782720086319,"version":"3.54.5"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["2017R1D1A1B03033486"],"award-info":[{"award-number":["2017R1D1A1B03033486"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.ejso.2020.08.023","type":"journal-article","created":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T11:20:40Z","timestamp":1600082440000},"page":"232-239","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Breast radiologic complete response is associated with favorable survival outcomes after neoadjuvant chemotherapy in breast cancer"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8888-3554","authenticated-orcid":false,"given":"Jinsun","family":"Woo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jai Min","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Mi","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Jun","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se Kyung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonghan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Eon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok Jin","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1564-0978","authenticated-orcid":false,"given":"Byung Joo","family":"Chae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2020.08.023_bib1","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1200\/JCO.1998.16.8.2672","article-title":"Effect of preoperative chemotherapy on the outcome of women with operable breast cancer","volume":"16","author":"Fisher","year":"1998","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2020.08.023_bib2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10549-008-0050-1","article-title":"Preoperative chemotherapy is safe in early breast cancer, even after 10 years of follow-up; clinical and translational results from the EORTC trial 10902","volume":"115","author":"van Nes","year":"2009","journal-title":"Breast Canc Res Treat"},{"key":"10.1016\/j.ejso.2020.08.023_bib3","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1093\/annonc\/mdx308","article-title":"De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen international expert consensus conference on the primary therapy of early breast cancer 2017","volume":"28","author":"Curigliano","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2020.08.023_bib4","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1245\/s10434-015-4403-9","article-title":"Role of imaging in neoadjuvant therapy for breast cancer","volume":"22","author":"Dialani","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2020.08.023_bib5","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1002\/bjs.10544","article-title":"Neoadjuvant chemotherapy with MRI monitoring for breast cancer","volume":"104","author":"Dave","year":"2017","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejso.2020.08.023_bib6","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1002\/cncr.27995","article-title":"Magnetic resonance imaging as a predictor of pathologic response in patients treated with neoadjuvant systemic treatment for operable breast cancer. Translational Breast Cancer Research Consortium trial 017","volume":"119","author":"De Los Santos","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.ejso.2020.08.023_bib7","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s40064-016-1800-x","article-title":"Accuracy of magnetic resonance imaging for predicting pathological complete response of breast cancer after neoadjuvant chemotherapy: association with breast cancer subtype","volume":"5","author":"Fukuda","year":"2016","journal-title":"SpringerPlus"},{"key":"10.1016\/j.ejso.2020.08.023_bib8","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1245\/s10434-011-1919-5","article-title":"Accuracy of clinical examination, digital mammogram, ultrasound, and MRI in determining postneoadjuvant pathologic tumor response in operable breast cancer patients","volume":"18","author":"Croshaw","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2020.08.023_bib9","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13058-018-0950-x","article-title":"MRI-based response patterns during neoadjuvant chemotherapy can predict pathological (complete) response in patients with breast cancer","volume":"20","author":"Goorts","year":"2018","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.ejso.2020.08.023_bib10","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1200\/JCO.2011.38.8595","article-title":"Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes","volume":"30","author":"von Minckwitz","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2020.08.023_bib11","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0140-6736(13)62422-8","article-title":"Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis","volume":"384","author":"Cortazar","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ejso.2020.08.023_bib12","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10549-005-4615-y","article-title":"Patterns of local and distant disease relapse in patients with breast cancer treated with primary chemotherapy: do patients with a complete pathological response differ from those with residual tumour in the breast?","volume":"93","author":"Chaturvedi","year":"2005","journal-title":"Breast Canc Res Treat"},{"key":"10.1016\/j.ejso.2020.08.023_bib13","doi-asserted-by":"crossref","first-page":"986","DOI":"10.3348\/kjr.2015.16.5.986","article-title":"Prognostic significance of a complete response on breast MRI in patients who received neoadjuvant chemotherapy according to the molecular subtype","volume":"16","author":"Ko","year":"2015","journal-title":"Korean J Radiol"},{"key":"10.1016\/j.ejso.2020.08.023_bib14","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13058-016-0742-0","article-title":"Survival is associated with complete response on MRI after neoadjuvant chemotherapy in ER-positive HER2-negative breast cancer","volume":"18","author":"Loo","year":"2016","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.ejso.2020.08.023_bib15","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.1245\/s10434-019-07534-1","article-title":"Survival outcomes for patients with clinical complete response after neoadjuvant chemotherapy: is omitting surgery an option?","volume":"26","author":"Ozkurt","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2020.08.023_bib16","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s13244-013-0219-y","article-title":"The role of magnetic resonance imaging in assessing residual disease and pathologic complete response in breast cancer patients receiving neoadjuvant chemotherapy: a systematic review","volume":"4","author":"Lobbes","year":"2013","journal-title":"Insights Imag"},{"key":"10.1016\/j.ejso.2020.08.023_bib17","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/jnci\/djs528","article-title":"Meta-analysis of magnetic resonance imaging in detecting residual breast cancer after neoadjuvant therapy","volume":"105","author":"Marinovich","year":"2013","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.ejso.2020.08.023_bib18","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1007\/s00330-002-1730-6","article-title":"Accuracy of tumor size measurement in breast cancer using MRI is influenced by histological regression induced by neoadjuvant chemotherapy","volume":"13","author":"Wasser","year":"2003","journal-title":"Eur Radiol"},{"key":"10.1016\/j.ejso.2020.08.023_bib19","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10549-005-9025-7","article-title":"Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer","volume":"95","author":"Fleissig","year":"2006","journal-title":"Breast Canc Res Treat"},{"key":"10.1016\/j.ejso.2020.08.023_bib20","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1056\/NEJMoa012782","article-title":"A\u00a0randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer","volume":"349","author":"Veronesi","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ejso.2020.08.023_bib21","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1200\/JCO.2006.07.4062","article-title":"Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011","volume":"25","author":"Lucci","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2020.08.023_bib22","first-page":"180","article-title":"Magnetic resonance imaging for axillary breast cancer metastasis in the neoadjuvant setting: a prospective study","volume":"17","author":"Mattingly","year":"2017","journal-title":"Clin Breast Canc"},{"key":"10.1016\/j.ejso.2020.08.023_bib23","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1245\/s10434-013-3118-z","article-title":"Imaging response and residual metastatic axillary lymph node disease after neoadjuvant chemotherapy for primary breast cancer","volume":"20","author":"Hieken","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2020.08.023_bib24","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13058-018-1091-y","article-title":"Radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer predicts recurrence-free survival but not pathologic complete response (pCR)","volume":"21","author":"Gampenrieder","year":"2019","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.ejso.2020.08.023_bib25","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1001\/jamasurg.2017.0562","article-title":"Identification of patients with documented pathologic complete response in the breast after neoadjuvant chemotherapy for omission of axillary surgery","volume":"152","author":"Tadros","year":"2017","journal-title":"JAMA Surg"},{"key":"10.1016\/j.ejso.2020.08.023_bib26","doi-asserted-by":"crossref","first-page":"169","DOI":"10.4174\/astr.2019.96.4.169","article-title":"Nomogram for accurate prediction of breast and axillary pathologic response after neoadjuvant chemotherapy in node positive patients with breast cancer","volume":"96","author":"Choi","year":"2019","journal-title":"Ann Surg Treat Res"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798320307150?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798320307150?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:37:12Z","timestamp":1760060232000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798320307150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S0748798320307150"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2020.08.023","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Breast radiologic complete response is associated with favorable survival outcomes after neoadjuvant chemotherapy in breast cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2020.08.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}